Rowe, W.; Cheng, X.; Ly, L.; Zhuang, T.; Basadonna, G.; Trink, B.; Keidar, M.; Canady, J.
The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner. Plasma 2018, 1, 177-188.
https://doi.org/10.3390/plasma1010016
AMA Style
Rowe W, Cheng X, Ly L, Zhuang T, Basadonna G, Trink B, Keidar M, Canady J.
The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner. Plasma. 2018; 1(1):177-188.
https://doi.org/10.3390/plasma1010016
Chicago/Turabian Style
Rowe, Warren, Xiaoqian Cheng, Lawan Ly, Taisen Zhuang, Giacomo Basadonna, Barry Trink, Michael Keidar, and Jerome Canady.
2018. "The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner" Plasma 1, no. 1: 177-188.
https://doi.org/10.3390/plasma1010016
APA Style
Rowe, W., Cheng, X., Ly, L., Zhuang, T., Basadonna, G., Trink, B., Keidar, M., & Canady, J.
(2018). The Canady Helios Cold Plasma Scalpel Significantly Decreases Viability in Malignant Solid Tumor Cells in a Dose-Dependent Manner. Plasma, 1(1), 177-188.
https://doi.org/10.3390/plasma1010016